Please Wait

Applying Filters...

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

DSSTox_CID_3652

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 NDC API, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 1 FDA Orange Book, 3 Europe, 1 Canada, 1 Australia, 1 South Africa, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 2 DFE Pharma, 1 Gangwal Chemicals, 14 Kerry, 9 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Pluviaendo, 1 Prachin Chemical, 5 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Silverline Chemicals, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Fillers, Diluents & Binders, 11 Lubricants & Glidants, 5 Coating Systems & Additives, 5 Film Formers & Plasticizers, 5 Granulation, 4 Direct Compression, 3 Co-Processed Excipients, 2 Emulsifying Agents, 2 Thickeners and Stabilizers, 1 Disintegrants & Superdisintegrants, 1 API Stability Enhancers, 1 Parenteral, 1 Topical